{
    "2020-11-09": [
        [
            {
                "time": "2021-11-09",
                "original_text": "Dr. Alice Chen on what the next steps are for Pfizer after company finds COVID-19 vaccine to be 90% effective",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "COVID-19 vaccine",
                        "90% effective"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-11-09",
                "original_text": "Everything We Know About Pfizerâ€™s Covid-19 Vaccine",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Covid-19 Vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "A Handful of Start-Ups Is Developing Psychedelic Drugs for Mental Illnesses. It Could Be a Bad Trip for Investors.",
                "features": {
                    "keywords": [
                        "start-ups",
                        "psychedelic drugs",
                        "mental illnesses",
                        "investors"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-17",
                "original_text": "Analyzing Johnson & Johnson's Unusual Options Activity",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "options activity"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-10",
                "original_text": "COVID-19 vaccine must be released soon or stock market could drop more than 10%: Goldman Sachs",
                "features": {
                    "keywords": [
                        "COVID-19 vaccine",
                        "stock market",
                        "Goldman Sachs"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-18",
                "original_text": "Johnson & Johnson (NYSE:JNJ) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "fundamentals",
                        "market perception"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}